SPHAERO
→
Domaines
Revues
Institutions
Collections
À propos
Nos services
Connexion
S'inscrire
FR
EN
→
Domaines
Revues
Institutions
Collections
À propos
Nos services
Connexion
S'inscrire
JO
Jubin Osei-Mensah
Publications (10)
Assessing the efficacy of high-dose rifampicin plus albendazole against onchocerciasis
Article scientifique · 2026
Humoral immune response to COVID-19 vaccines in onchocerciasis-infected individuals: a field study from Ghana
Article scientifique · 2025
Association of haemato-biochemical indices and blood composite ratios with microfilaridermia in Onchocerciasis patients
Article scientifique · 2024
Occurrence of Onchocerciasis infection after decades of mass drug administration in the Western North Region of Ghana: The case of Sefwi Akontombra district
Article scientifique · 2022
Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana
Article scientifique · 2022
Filarial Lymphedema Patients Are Characterized by Exhausted CD4+ T Cells
Article scientifique · 2022
Distinct Immune Profiles of Exhausted Effector and Memory CD8+ T Cells in Individuals With Filarial Lymphedema
Article scientifique · 2021
Morbidity management and surveillance of lymphatic filariasis disease and acute dermatolymphangioadenitis attacks using a mobile phone-based tool by community health volunteers in Ghana
Article scientifique · 2020
Single nucleotide polymorphisms in the angiogenic and lymphangiogenic pathways are associated with lymphedema caused by Wuchereria bancrofti
Article scientifique · 2017
Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot Trial
Article scientifique · 2017
Domaines principaux
Sciences de la santé
10
Statistiques
Consultations
28
Téléchargements
0
Votre avis compte
Une suggestion, un bug, un ressenti sur SPHAERO ? Une minute suffit.
Plus tard
Donner mon avis
Votre avis compte
Nom
(optionnel)
Courriel
(optionnel)
Type de retour
Suggestion
Avis général
Signaler un bug
Message
Annuler
Envoyer
Merci, votre message a bien été envoyé.